Sign in to view content

Anti-VEGF Injection Prior Authorization Impacts on Retina Practices

Sabin Dang, MD

Video
Published 2022

Related

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
National Cohort Study on New Oral Hypoglycemic Agents in Diabetic Retinopathy Progression
Ehsan Rahimy, MD
Annual Meeting Talks
2023
Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial
Peter A. Campochiaro, MD
Updates from the Field
2021

Category: Practice Management

See more